Distress and depression in cancer patients – diagnosis and treatment Review article
Article Sidebar
Main Article Content
Abstract
Cancer diagnosis destroys previous internal and external order of patient, who has not experienced such a situation yet. The most negative emotions, which are felt in the situation of cancer diagnoses are anxiety, sadness, anger, distress and concern about the continued existence and functionality, which can also lead to depression. It becomes essential to identify the grade of bigger distress and depression, which increase suffering of the patient, reduce the effectiveness of therapy, as well as significantly raise the risk of suicide among cancer patients. Article presents general assumptions related to the epidemiology of distress and depression in cancer, diagnostic and range of possible therapies that can be used to treat cancer patients.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Ducrocq F., Vaiva G., Cottencin O., Molenda S., Bailly D.: Post-traumatic stress, post-traumatic depression and major depressive episode: literature. Encephale. 2001 Mar-Apr; 27(2): 159-68.
3. Koutrouli N., Anagnostopoulos F., Potamianos G.: Posttraumatic stress disorder and posttraumatic growth in breast cancer patients: a systematic review. Women Health 2012 Jul; 52(5): 503-16.
4. Posluszny D.M., Baum A., Edwards R.P., Dew M.A.: Posttraumatic growth in women one year after diagnosis for gynecologic cancer or benign conditions. J. Psychosoc. Oncol. 2011 Sep-Oct; 29(5): 561-72.
5. Gregory R.J., Jimerson D.C., Walton B.E., Daley J., Paulsen R.H.: Pharmacotherapy of depression in the medically ill: directions for future research. Gen. Hosp. Psychiatry 1992 Jan; 14(1): 36-42.
6. Wascher R.A.: A Cancer Prevention Guide for the Human Race. Dog Ear Publishing, Indianapolis 2012.
7. Onitilo A.A., Nietert P.J., Egede L.E.: Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen. Hosp. Psychiatry 2006 Sep-Oct; 28(5): 396-402.
8. Gil F., Grassi L., Travado L., Tomamichel M., Gonzalez J.R.; Southern European Psycho-Oncology Study Group. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer 2005 Aug; 13(8): 600-6.
9. Massie M.J.: Prevalence of depression in patients with cancer. J. Natl. Cancer Inst. Monogr. 2004; 32: 57-71.
10. Hopwood P., Stephens R.J.: Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J. Clin. Oncol. 2000 Feb; 18(4): 893-903.
11. Holland J.C.: Psychological care of patients: psycho-oncology’s contribution. American Cancer Society Award Lecture. J. Clin. Oncol. (Suplement) 2003; 21: 253-265.
12. Koch U., Mehnert A.: Psychosocial assessment in cancer patients. IPOS. Online: www.ipos-society.org.
13. National Comprehensive Cancer Network. Distress Treatment Guidelines for Patients. Version 1.2011. NCCN 2011, Rockledge, Pennsylvania. Online: http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf .
14. Kieszkowska-Grudny A.: Ocena jakości życia chorych z rozpoznaniem raka płuca i choroby serca. W: Postępowanie w powikłaniach sercowo-naczyniowych w raku płuca. Krzakowski M., Opolski G. i Szmit S. (red.). Medical Education, Warszawa 2012: 111-134.
15. Cohen-Cole S.A., Brown F.W., McDaniel S.: Diagnostic assessment of depression in the medically ill. W: Principles of medical psychiatry. Stoudemire A., Fogel B. (red.). Oxford University Press, New York 1993: 53-68.
16. Newport D.J., Nemeroff C.B.: Assessment and treatment of depression in the cancer patient. J. Psychosom. Res. 1998 Sep; 45(3): 215-37.
17. Wise M.G., Rundell J.: The American Psychiatric Publishing Textbook of Consultation-Liaison Psychiatry: Psychiatry in the Medically Ill. American Psychiatric Pub., 2002: 1160.
18. Hem E., Loge J.H., Haldorsen T., Ekeberg Ø.: Suicide risk in cancer patients from 1960 to 1999. J. Clin. Oncol. 2004 Oct 15; 22(20): 4209-16.
19. Chochinov H.M., Wilson K.G., Enns M., Mowchun N., Lander S., Levitt M., Clinch J.J.: Desire for death in the terminally ill. Am. J. Psychiatry 1995 Aug; 152(8): 1185-91.
20. Chochinov H.M., Wilson K.G., Enns M., Lander S.: “Are you depressed?” Screening for depression in the terminally ill. Am. J. Psychiatry 1997 May; 154(5): 674-6.
21. Erikson E.H.: Identity and the Life Cycle. (re-issue 1959). WW Norton & Company, New York 1994.
22. Kissane D.W., Clarke D.M., Street A.F.: Demoralization syndrome – a relevant psychiatric diagnosis for palliative care. Journal of Palliative Care 2001; 17: 12-21.
23. Kissane D.W., Wein S., Love A., Lee X.Q., Kee P.L., Clarke D.M.: The Demoralization Scale: a report of its development and preliminary validation. Journal of Palliative Care 2004; 20: 269-276.
24. Grassi L., Riba M.: W: Depressive Disorders in Physical Illness. Riba M., Grassi L. (red.). World Psychiatric Association, Geneve 2008: 67-81, 200.